儿童和青少年无诱因静脉血栓栓塞症复发率高
这项单中心回顾性队列研究纳入2003至2021年间85例1至<21岁无诱因静脉血栓栓塞症(VTE)患儿,随访250人年发生26例复发(发生率为每1000人年104例,95%CI 71-153)。首次VTE年龄≥12岁(HR 7.56)和遗传性易栓症(HR 2.28)与复发显著相关;26例复发中12例(46%)发生在抗凝治疗期间。
要点
- 儿童无诱因VTE复发率为每1000人年104例(95%CI 71-153)。
- 首次VTE年龄≥12岁(HR 7.56)和遗传性易栓症(HR 2.28)与复发显著相关。
- 26例复发中12例(46%)发生在抗凝治疗期间。
核心结论
- 儿童无诱因VTE患者复发率高,尤其是青少年和遗传性易栓症患者。
- 未来研究应关注延长抗凝治疗对该人群的疗效。
研究设计与样本
- 单中心、回顾性队列研究。
- 纳入2003至2021年间1至<21岁发生首次无诱因VTE的儿童,共85例符合标准。
主要发现
- 随访250人年发生26例复发,复发率为每1000人年104例(95%CI 71-153)。
- 首次VTE年龄≥12岁与复发显著相关(HR 7.56;95%CI 1.60-35.83)。
- 遗传性易栓症与复发显著相关(HR 2.28;95%CI 1.05-4.95)。
- 女性复发风险降低但未达统计学显著(HR 0.56;95%CI 0.25-1.27)。
- 门诊治疗性抗凝中位持续时间为274天(IQR 101-2357)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Unprovoked venous thromboembolism (VTE) is rare in pediatrics. Current recommendations for anticoagulation duration after unprovoked VTE differ for pediatric and adult populations. OBJECTIVES: This single-center, retrospective cohort study aimed to determine the incidence rate of recurrent VTE in children and adolescents with unprovoked VTE, evaluate the potential risk factors for recurrence, and describe the anticoagulation regimens and bleeding in this population. METHODS: Children with an index, unprovoked VTE at the age of 1 to <21 years between 2003 and 2021 were included. The time to recurrent VTE and anticoagulation duration were summarized using Kaplan-Meier estimators. Clinical covariates were assessed for association with recurrence using stratified Kaplan-Meier curves and univariate Cox proportional hazards regression. RESULTS: Eighty-five children met the inclusion criteria, and there were 26 recurrent events in 250 person-years of follow-up (incidence rate = 104 [95% CI, 71-153] per 1000 person-years). An age of ≥12 years at index VTE (hazard ratio [HR], 7.56; 95% CI, 1.60-35.83) and inherited thrombophilia (HR, 2.28; 95% CI, 1.05-4.95) were significantly associated with recurrent VTE. Female sex had a nonstatistically significant decreased hazard of recurrence (HR, 0.56; 95% CI, 0.25-1.27). Duration of anticoagulation was variable, with a median duration of 274 days (IQR, 101-2357) for outpatient therapeutic anticoagulation. Twelve of the 26 (46%) recurrent events occurred while anticoagulation was prescribed. CONCLUSION: The incidence rate of recurrent VTE in pediatric patients with a prior unprovoked VTE is high, particularly for adolescents and those with inherited thrombophilia. Therefore, future research should focus on the efficacy of prolonged anticoagulation for this population.
引用
- Whitworth H, Clark HH, Hubbard RA, et al. High rate of recurrent venous thromboembolism in children and adolescents with unprovoked venous thromboembolism. J Thromb Haemost. 2022. PMID: 36695395. doi:10.1016/j.jtha.2022.11.031
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。